Cardiovascular-Kidney-Metabolic Livestream

Register now
  • Nov. 12 – 13, 2026 (Thu–Fri)
  • Online
  • 12 Credits
  • Member$815
  • Non-Member$1025
  • New Physician$765
  • Student$645
  • Resident$645
  • Other$815

Purchases may be subject to applicable sales tax.

Register by October 30, 2026 to save $100!

Final credit amount pending. Minimum 12 credits.

Join us for this dynamic, two-day online CME conference on what the American Heart Association identified as Cardiovascular-Kidney-Metabolic (CKM) Syndrome.

You will be encouraged to be a part of the conversation as we discuss overlapping co- and multi-morbidity cases related to CKM syndrome. Shift and advance your therapeutic decision-making from managing individual diseases to managing them as a syndrome.

Join us for this dynamic, two-day online CME conference on what the American Heart Association identified as Cardiovascular-Kidney-Metabolic (CKM) Syndrome.

You will be encouraged to be a part of the conversation as we discuss overlapping co- and multi-morbidity cases related to CKM syndrome. Shift and advance your therapeutic decision-making from managing individual diseases to managing them as a syndrome.

Course details

  • Apply the AHA Cardiovascular-Kidney-Metabolic (CKM) framework and CKM staging to complex patient cases to recognize interrelated cardiometabolic, renal, and cardiovascular risk factors in primary care.

  • Use evidence-based screening, risk stratification, treatment intensification, referral, and follow-up strategies for patients with overlapping CKM conditions.

  • Integrate GLP-1 receptor agonists, SGLT2 inhibitors, lifestyle interventions, and other guideline-directed therapies into individualized care plans for patients with obesity, diabetes, chronic kidney disease, cardiovascular disease or heart failure.

  • Differentiate heart failure phenotypes and chronic kidney disease stages to inform treatment, referral and care coordination decisions in real-world CKM cases.

  • Develop practical, patient-centered management strategies that address multimorbidity, medication burden, access considerations and team-based care needs for patients with complex CKM risk and disease.

Through participatory PBLs you’ll turn complex, real world cases into advanced knowledge for stronger clinical decision-making. Here’s what you can expect as we dive into each stage of CKM:

  • Stage 0

    Detect disease markers sooner and implement evidence-based lifestyle changes earlier. Assess cardio metabolic risk using the PREVENT calculator.

  • Stage 1

    Identify and reduce central adiposity/ obesity through both non-pharmacologic and pharmacologic interventions.

  • Stage 2

    Identify and treat early signs of metabolic risk factors through new evidence-based non-pharmacologic/pharmacologic interventions to prevent CKD and stop progression.

  • Stage 3

    Identify subclinical CVD using specified screening tools and implement treatment before they progress to clinical CVD.

  • Stage 4

    Strengthen skills to better detect clinical signs of CHD and implement appropriately timed treatment strategies that reduce morbidity and mortality.

Schedule (all times CST)

8:00 – 8:30 a.m.
Welcome and Introduction of CKM – Justin Bailey, MD

Stages 0–1: Focus on Prevention and Reducing the Development of Problematic Adiposity

8:30 – 9:15 a.m.
Putting CKM Staging into Practice: Identifying Risk Earlier in Complex Primary Care Patients

9:15 – 10:15 a.m.
Lifestyle Intervention in CKM: Practical Strategies That Reduce Risk and Support Long-Term Health

10:15 – 10:30 a.m.
Break

10:30 – 11:30 a.m.
Combating Misinformation and Social Media in Preventative CKM Care

11:30 a.m. – 12:30 p.m.
Lunch

Stage 2: Focus on Reducing Metabolic Risk and CKD

12:30 – 12:45 p.m.
Setting the Stage: Why CKM Stage 2 Matters in Primary Care – Justin Bailey, MD

12:45 – 1:45 p.m.
Lipid Management in CKM: Applying Guideline Updates to Reduce Cardiovascular Risk

1:45 – 2:30 p.m.
Diabetes Management in CKM: Applying New Evidence to Reduce Kidney and Cardiovascular Risk

2:30 – 2:45 p.m.
Break

2:45 – 3:30 p.m.
Blood Pressure Targets in CKM: Reconciling Guidelines for Real-World Primary Care

3:30 – 4:30 p.m.
Anemia in CKM: Recognizing Risk, Evaluating Causes, and Coordinating Care

4:30 p.m.
Recess

Stages 3 and 4 – Treatment of Subclinical and Clinical CVD

8:30 – 8:45 a.m.
Advancing CKM Care: Recognizing Stages 3–4 and Coordinating Treatment for Complex Disease – Justin Bailey, MD

8:45 – 9:30 a.m.
Coronary Disease in CKM: Preventing Events and Managing Angina, MI, and Residual Risk

9:30 – 10:15 a.m.
Cerebrovascular Disease in CKM: Reducing Stroke Risk Through Integrated Primary Care

10:15 – 10:30 a.m.
Break

10:30 – 11:15 a.m.
Heart Failure in CKM: Phenotyping, Treatment Intensification, and Team-Based Follow-Up

11:15 a.m. – 12:00 p.m.
Arrhythmias in CKM: Managing Atrial Fibrillation and Rhythm Risk in Complex Patients

12:00 – 1:00 p.m.
Lunch

1:00 – 1:45 p.m.
Social Drivers of CKM Health: Identifying Barriers and Building Practical Care Plans

1:45 – 2:00 p.m.
Deprescribing in CKM: Balancing Guideline-Directed Care, Frailty, and Patient Goals

2:00 – 2:45 p.m.
Patient Motivation in Primary Prevention

2:45 – 3:00 p.m.
Break

Case Studies/Problem Based Learning covering all stages

3:00 – 3:30 p.m.
Case Studies/Problem-Based Learning – Early CKM Risk in Practice: Case-Based Prevention for Stages 0–1

3:30 – 4:00 p.m.
Case Studies/Problem-Based Learning – CKM Stage 2 Cases: Reducing Metabolic Risk and Slowing Progression

4:00 – 4:30 p.m.
Case Studies/Problem-Based Learning –Advanced CKM Cases: Managing Stages 3–4, Multimorbidity, and Referral Decisions

4:30 p.m.
Adjourn

Cardiovascular-Kidney-Metabolic Livestream

Register now